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Introduction
The prevalence of hypersensitivity drug reactions (HDRs) is increasing, and nonsteroidal anti-inflammatory drugs (NSAIDs) are now the most common culprits [1] . The most frequently induced clinical entity in NSAID HDRs is NSAID-induced urticaria and/or angioedema (NIUA) [1] , the mechanism of which is thought to be related to cyclooxygenase-1 inhibition in susceptible individuals [2, 3] . This mechanism has also been suggested for aspirin-intolerant chronic urticaria [4] .
Thymic stromal lymphopoietin (TSLP), a cytokine produced by epithelial cells, can initiate and maintain the inflammatory response [5, 6] and has been shown to be overexpressed in the affected skin of patients with cutaneous diseases [7, 8] . Several candidate gene association studies have assessed the importance of TSLP in NSAIDexacerbated respiratory disease (NERD) [9] , atopic dermatitis [10] and eczema [11] , as well as other allergy-related pathologies. In addition, genome-wide association studies have found single nucleotide polymorphism (SNPs) in TSLP to be associated with asthma [12] , allergic rhinitis [13, 14] and eosinophilic esophagitis in children [15] .
Given the importance of TSLP in these inflammatory diseases and its role as a key cytokine in the initiation of inflammatory disease, we hypothesized that genetic variants in this gene and those encoding its receptor subunits could be implicated in NIUA susceptibility. Therefore, in this study we assessed the association of common SNPs in TSLP , TSLPR and IL7R with NIUA.
Materials and Methods

Study Population
This study was performed using a case-control design and included unrelated individuals of Spanish descent: 377 NIUA patients and 585 controls. All participants signed an informed consent and the protocols were approved by the institutional ethics committee (Comité Coordinador de Ética de la Investigación Biomédica de Andalucía), following the ethical principles declared in the Declaration of Helsinki.
NIUA patients (cases) were diagnosed by clinical history, having presented more than two hypersensitivity reactions (urticaria and/or angioedema) to at least two different NSAIDs, and had no history of chronic urticaria [16] . Patients who had suffered less than three episodes were subjected to an oral provocation test (OPT) with aspirin to confirm diagnosis [17] . A detailed clinical algorithm, combining OPT and clinical history for patient diagnosis, has been described previously [16] [17] [18] . The control group consisted of individuals with no previous history of HDRs and with a negative OPT to NSAIDs. All participants were recruited by the allergy services of two hospitals belonging to the RIRAAF (Spanish National Network for Drug Allergy).
The atopic status was determined by skin prick test (SPT) for cases and controls. SPT was performed with a set of common inhalant allergens, including pollens, house dust mites, molds and animal danders (ALK, Madrid, Spain). A positive SPT was defined as a weal diameter at least 3 mm larger than the negative control to at least one allergen. The patients were requested to stop taking any antihistamine-containing medications at least 10 days before testing. An individual was considered atopic if he/she showed a positive SPT. The clinical and demographic characteristics of the study subjects and culprit drugs are shown in table 1 .
Selection of SNPs
Tag SNPs, informative of other common genetic variations in the TLSP, IL7R and TSLPR genes, were selected using Haploview based on information from the HapMap II database [19] , including 10 kb of flanking regions for each gene and using variants with a minor allele frequency (MAF) ≥ 0.10 and an r 2 ≥ 0.8 [10, 20] .
Genotyping
Genomic DNA was extracted from peripheral white blood cells using the FlexiGene DNA kit (Qiagen, Hilden, Germany) following the manufacturer's protocol. Sample quantification was performed using Quant-iT PicoGreen dsDNA reagents (Invitrogen, Waltham, Mass., USA).
Genotyping was carried out using TaqManG probes for each selected SNP. Custom assays were used to genotype rs1494565 in IL7R and the three TSLPR SNPs; table 2 describes the sequence utilized for designing these custom assays. For the remaining SNPs, assay serial numbers as provided by the manufacturer are given in table 2 . Genotyping and allelic discrimination was performed using the 7500 Fast Real-Time PCR System (Life Technologies, Carlsbad, Calif., USA).
Statistical Analysis
Clinical and demographical data were analyzed using R program version 3.1.2 by χ 2 test and the Mann-Whitney U test. Qual- 251 ity control was performed using PLINK [21] to discard SNPs with a completion rate (CR) <90%, MAF <0.05 and deviation from Hardy-Weinberg equilibrium (HWE) with p < 0.0033 (i.e. a Bonferroni correction; corresponding to a threshold calculated by dividing the nominal threshold of 0.05 for a single test by the total number of SNPs tested). Samples with a CR <80% were discarded.
To perform the imputation of additional variants in our candidate genes, we downloaded the 1,000 Genomes Project Phase 3 data [22] and used VCFtools to extract the variants from the regions of interest [23] . PLINK was then used to extract the data from the 503 European individuals included in the dataset. Imputation was carried out with Mach software (version 1.0.16) [24] . Association testing was performed with Mach2dat, which uses logistic regression based on the inferred allele count (allele dosage) [25] . SNPs with MAF <0.10 and RSQR <0.3 were removed from further analyses. RSQR is an imputation quality measure, defined as the correlation (r 2 ) between genotyped and imputed SNP values. Data were presented as regional plots using Locus Zoom [26] . A false discovery rate (FDR) was computed using q value for R [27] , and an FDR ≤ 5% was considered significant. Statistical power was calculated using Quanto (http://biostats. usc.edu/software) taking into account the number of independent SNPs for each gene as estimated with SNPSpD (https://genepi. qimr.edu.au/). The statistical power for two-tailed associations was 81.89% for risk alleles with MAF = 0.4.
Results
Five control and 8 case subjects did not pass quality control due to a genotype CR below 80%, leaving the study with 580 control subjects and 369 NIUA patients for further analyses. No significant differences for age and sex were found between the two groups ( table 1 ). Statistically significant differences were found between NIUA patients and the controls for atopic status (p < 0.0001). The main culprit drugs were propionic acid derivatives (35.3%) followed by aspirin (23.2%; table 1 ).
A total of 15 SNPs were genotyped ( table 2 ). All SNPs had an MAF >0.10 in controls and a p value greater than 0.0033 (0.05/15) for HWE. TSLP and IL7R SNPs had a CR >90%, whereas SNPs in TSLPR (rs36139698, rs36177645, rs36133495) showed a CR <90% and were therefore excluded from further analyses.
After imputation and quality control filters, a total of 29 TSLP variants and 110 IL7R variants were analyzed for association studies (online suppl. tables S1 and S2; see www.karger.com/doi/10.1159/000444797 for all online suppl. material). Out of the 139 SNPs tested, none of the variants in IL7R showed a significant association with NIUA (online suppl. table S2), and only two SNPs in TSLP (rs1816678 and rs764917) showed a nominal association with NIUA (p = 0.033 and 0.024, respectively; table 3 ; online suppl. fig. S1 ). These associations suggested a protective effect for the rs1816678-G allele (odds ratio = 0.76) and rs764917-A allele (odds ratio = 0.81). However, neither of these results were significant following FDR correction (FDR = 31.5% for both). No association was found between any of the common SNPs analyzed here and atopy, either before or after applying a multiple testing correction.
Discussion
In this study we assessed the association between genetic variants in TSLP , IL7R and TSLPR , and NIUA. TSLP could act through mast cell activation to stimulate the release of Th2 cytokines, which are implicated in the regulation of the arachidonic acid pathway [28, 29] . Another potential mechanism of action could be through the TSLP-activated pSTAT5 pathway leading to FCER1G demethylation and FcεRI overexpression [30] ; this mechanism could have a role in NSAID hypersensitivity, perhaps in conjunction with variation in the IgE receptor genes, which have been shown to be associated with this pathology, although results are mixed [31] [32] [33] [34] .
TSLP polymorphisms have been studied in the context of respiratory [12] [13] [14] [35] [36] [37] and cutaneous diseases [10] [11] , including NERD [9] . However, in this study only two imputed SNPs showed a nominal genetic association (rs1816678 and rs764917) with NIUA, suggesting a potential role of TSLP in NIUA, although this must be confirmed.
The SNP rs1816678 is located 9.6 kb upstream of TSLP . This polymorphism has been predicted to alter the lipidactivated nuclear receptor (LXR) and Sp4 transcription factor regulatory motifs [38] . By affecting LXR regulation, this SNP may alter lipid homeostasis and inflammation [39] , whilst changes in Sp4 activity may have a role in neuroinflammation [40] . Nevertheless, the potential role of this SNP in NIUA needs further study.
The second SNP, rs764917, is located in an intergenic region 5.3 kb 5 ′ of TSLP . It has been proposed to influence transcriptional regulatory mechanisms [36] . In fact, this SNP is predicted to alter five regulatory motifs for BarHlike homeobox 1 (Barhl1), cycling T2 (CCNT2), GATA binding protein (GATA), histone deacetylase 2 (HDAC2) and H6 family homeobox 2 (Hmx-2) [38] , which could affect TSLP regulation. Barhl1 is a transcriptional regulator [41] and CCNT2 is a subunit of the transcription elongation factor (TEFb) that it is part of the RNA polymerase II [42] . Barhl1, CCNT2 and Hmx-2 have not previously been associated with NIUA or allergic diseases; however, GATA is a superfamily of transcription factors implicated in the regulation of cellular differentiation of important immune cells, such as basophils [43] and eosinophils [44] . Specifically, GATA-3 is implicated in the development of Th2 responses in allergic dermatitis [45, 46] and in selective, single NSAID-induced urticaria/angioedema [47] . Furthermore, it has been suggested that GATA-3 blockage by corticosteroids could be used as a treatment for allergies due to the inhibition of the Th2 response [48] . More studies are needed to explore whether rs764917 may affect GATA regulation of TSLP . HDAC2 is a member of a transcriptional repressor complex involved in transcriptional regulation, cell cycle progression and development, and may have a role in asthma [49] [50] [51] , allergic disease [51] and COPD [52] . Moreover, an inhibitor of HDAC2 has been shown to be effective in preventing nasal polyposis [53] . In a previous genetic association study, a CC genotype at rs764917 was shown to have a protective effect for patients with chronic rhinosinusitis and nasal polyps [36] . Interestingly, in our study we found the A allele to be protective. To date, the relationship between changes in binding of HDAC2 due to rs764917 in HDRs to NSAIDs has not been analyzed.
Both IL7R and TSLPR have been shown to be important for TSLP signaling and functioning during the inflammatory response [54] . However, although several SNPs in IL7R have been associated with cutaneous diseases like atopic dermatitis [10] and lupus erythematosus [55] , we did not find any association with NIUA.
NSAIDs are highly prescribed for the treatment of pain, fever and inflammation, with more than ten million individuals using these drugs daily [56] . However, they are the main cause of HDRs [57] , including anaphylaxis reactions [58] . NIUA is the most frequent entity in NSAID HDRs; nevertheless, genetic association studies for this pathology are scarce [2, 17, [59] [60] [61] [62] [63] and have not previously analyzed the role of TSLP and its receptor in this clinical entity. Although there is still some controversy, it has been shown that aspirin-exacerbated cutaneous disease is a different subphenotype of chronic spontaneous urticaria [64] , representing a different entity to NIUA, which occurs in individuals without a history of underlying chronic urticaria [65] . Therefore, we compared NIUA patients to normal healthy controls and did not include NSAID-tolerant chronic spontaneous urticaria patients as a control. This approach has been used in previous genetic association studies of NIUA patients carried out by our group [62] .
In conclusion, we did not find any significant associations for common SNPs in the studied genes in a Spanish population of NIUA patients compared to healthy controls. However, we believe the suggestive association found for two TSLP SNPs warrants further study.
